Results 141 to 150 of about 6,479 (200)

Nucleoprotein and glycoprotein based serological assays for detection of Marburg virus infections. [PDF]

EBioMedicine
Kagame J, Kainulainen MH, Kabalisa E, Brangel P, Uwimana JMV, Harmon JR, Mohamed NS, Benimana JL, Umwari A, Karaaslan E, Gasengayire A, Akimana J, Murenzi H, Kabageni C, Sealy T, Rwagitinywa B, Gashegu M, Ahmed A, Jain S, Albariño CG, Choi MJ, Schuh AJ, Firew T, Karekezi E, Mwesigwa RCN, Tuyishime A, Towner JS, Roels TH, Mukagatare I, Dowling WE, Montgomery JM, Muvunyi CM, Spiropoulou CF, Ngabonziza JCS, Bergeron É.   +34 more
europepmc   +1 more source

Risk group-4 virus emergent threats. [PDF]

Bioinformation
Shapshak P, Balaji S, Somboonewit C, T Sinnott J, Chiappelli F.   +4 more
europepmc   +1 more source

Mapping the scientific landscape of Lassa virus: a 55-year bibliometric study (1970-2025). [PDF]

Sci One Health
Edet UO, Meseko C, Ali MZ, Imalele EE, Roseann AE, Eyo AO, Edet B, Asala O.   +7 more
europepmc   +1 more source

Safety, tolerability, immunogenicity, and plasmapheresis-based antibody collection in a phase 1b open label trial of two investigational monovalent chimpanzee adenoviral vectored filovirus vaccines, cAd3-Sudan and cAd3-Marburg, in healthy adults. [PDF]

EBioMedicine
Vert-Wong E, Stevenson ME, Rustomjee R, Finch CL, Jakubik J, King TH.   +5 more
europepmc   +1 more source

Decoding the blueprint of receptor binding by filoviruses through large-scale binding assays and machine learning. [PDF]

Cell Host Microbe
Lasso G, Grodus M, Valencia E, DeJesus V, Liang E, Delwel I, Bortz RH, Lupyan D, Ehrlich HY, Castellanos AA, Gazzo A, Wells HL, Wacharapluesadee S, Tremeau-Bravard A, Seetahal JFR, Hughes T, Lee J, Lee MH, Sjodin AR, Geldenhuys M, Mortlock M, Navarrete-Macias I, Gilardi K, Willig MR, Nava AFD, Loh EH, Asrat M, Smiley-Evans T, Magesa WS, Zikankuba S, Wolking D, Suzán G, Ojeda-Flores R, Carrington CVF, Islam A, Epstein JH, Markotter W, Johnson CK, Goldstein T, Han BA, Mazet JAK, Jangra RK, Chandran K, Anthony SJ.   +43 more
europepmc   +1 more source

Direct Intercellular Transport Mode of Filovirus Nucleocapsids. [PDF]

Int J Mol Sci
Ibrahim CHO, Takamatsu Y.
europepmc   +1 more source

Lack of Lloviu Virus Disease Development in Ferret Model. [PDF]

Emerg Infect Dis
Fletcher P, O'Donnell KL, Rhoderick JF, Henderson CW, Okumura A, Bushmaker T, Takada A, Clancy CS, Kemenesi G, Marzi A.   +9 more
europepmc   +1 more source

In Vivo Investigation of Filovirus Glycoprotein-Mediated Infection in a BSL2 Setting. [PDF]

Methods Mol Biol
Richards PT, Briseño JAA, Brunton BA, Maury W.   +3 more
europepmc   +1 more source

Filovirus vaccines as a response paradigm for emerging infectious diseases. [PDF]

NPJ Vaccines
Marzi A, Feldmann H.
europepmc   +1 more source

Měnglà Virus VP40 Localizes to the Nucleus and Impedes the RIG-I Signaling Pathway. [PDF]

Viruses
Sweeney Gibbons J, Thakur N, Komers E, Vogel OA, Chakraborty P, Tufariello JM, Basler CF.   +6 more
europepmc   +1 more source